Drug Information Association Logo
« Back to Listing

The Role of Intelligent Signaling in Digital Disease Detection and Proactive Pharmacovigilance

Track:
Clinical Safety and Pharmacovigilance

Day & Time:
June 18, 1:30PM - 2:30PM (Pacific Standard Time)

Session Number:
371

Room Number:
30AB

Level:
Intermediate

Type:
Session

Title:
The Role of Intelligent Signaling in Digital Disease Detection and Proactive Pharmacovigilance

Chair(s):
John S. Brownstein, PhD
Manager and Associate Professor
Boston Children's Hospital and Harvard Medical School, United States

Description:
This session will focus on the potential use of intelligent signaling systems to analyze electronic health records/electronic medical records (EHR/EMR) and social media data in an effort to augment safety profiling and understand the potential use of these data streams for uncovering early signals. Presenters will examine how the use of intelligent signaling systems in conjunction with traditional adverse event (AE) data systems can offer an improved automated surveillance system that may assist or even eventually replace manual individual case study report (ICSR) case assessment. The use of social media sources such as Facebook, Twitter, web searches, news reports, chat rooms, etc., to crowdsource data regarding disease outbreaks provides an opportunity to monitor, track and, ideally, forecast infectious disease outbreaks. These systems can make disease data publicly available earlier than traditional surveillance systems, therefore allowing us to limit their impact on communities. Collectively, these sources provide a view of global health that is fundamentally different from that yielded by the disease/AE reporting of the traditional public health infrastructure.


Learning Objective(s):
Discuss how social media can make disease data publicly available earlier than traditional surveillance systems, therefore allowing us to limit their impact on communities.

Presentation(s) & Speaker(s):
Automating Drug Safety Surveillance: Multisensory Signaling Using Health Care, Safety, and Social Media Data
Ambrish Mathur, MS
Vice President, Strategic Development
ArisGlobal, United States

Digital Drug Safety Surveillance
John S. Brownstein, PhD
Manager and Associate Professor
Boston Children's Hospital and Harvard Medical School, United States